Evelo Biosciences Publishes Study Titled 'EDP1867 Phase 1a/1b Study in Healthy Participants and Participants With Moderate Atopic Dermatitis and, Optionally, Moderate Psoriasis, and/or Mild Asthma' To ClinicalTrials.Gov Site